Overview
- 29 inspections across 27 sites are on record.
- 56 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-02-14.
At a glance
Inspections
29
Sites
27
Observations
56
Career since
Apr 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Hetero Drugs Limited | 14 Feb 2020 | Human Drugs | On file |
| Shilpa Pharma Lifesciences Limited | 7 Feb 2020 | Human Drugs | |
| Kyowa Hakko Bio Co. Ltd. | 8 Nov 2019 | Human Drugs | |
| Kyowa Hakko Bio Co., Ltd. | 8 Nov 2019 | Human Drugs | On file |
| Spectranetics Corporation | 14 Feb 2019 | Medical Devices & Rad Health |
Sites inspected
Hetero Drugs LimitedGummadidala Mandal, Sangareddy, India1 insp.
Shilpa Pharma Lifesciences LimitedChicksugur, Raichur, India1 insp.
Kyowa Hakko Bio Co. Ltd.Ube, Japan1 insp.
Kyowa Hakko Bio Co., Ltd.Hofu, Japan1 insp.
Spectranetics CorporationFremont, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Emily J Orban6 shared
Michele L Forster4 shared
Rebecca E Dombrowski3 shared
Jeffrey D Meng3 shared
Michael L Casner2 shared
Margaret M Annes2 shared
Ileana Barreto-Pettit2 shared
Barbara J Breithaupt2 shared
Maida Henesian1 shared
Nicholas L Paulin1 shared
Full investigator report
Get the verbatim findings behind Sneha S Patel's 56 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site